pubmed-article:21395567 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21395567 | lifeskim:mentions | umls-concept:C0085637 | lld:lifeskim |
pubmed-article:21395567 | lifeskim:mentions | umls-concept:C0064636 | lld:lifeskim |
pubmed-article:21395567 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
pubmed-article:21395567 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21395567 | pubmed:dateCreated | 2011-3-14 | lld:pubmed |
pubmed-article:21395567 | pubmed:abstractText | We report four patients with no preexisting movement disorders who developed oculogyric crises secondary to lamotrigine toxicity and had resolution of these crises after dose reduction. Episode numbers ranged from 1-20 per day and episode duration from 2 s to several hours. Mean plasma concentration of lamotrigine at the time of oculogyric crisis was 15.5 ?g/mL, with a mean dose of 16 mg/kg per day. | lld:pubmed |
pubmed-article:21395567 | pubmed:language | eng | lld:pubmed |
pubmed-article:21395567 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21395567 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21395567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21395567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21395567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21395567 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21395567 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21395567 | pubmed:issn | 1528-1167 | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:BakerJohnJ | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:MikatiMohamad... | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:GallentineWil... | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:Veerapandiyan... | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:WinchesterSar... | lld:pubmed |
pubmed-article:21395567 | pubmed:author | pubmed-author:KansagraSujay... | lld:pubmed |
pubmed-article:21395567 | pubmed:copyrightInfo | Wiley Periodicals, Inc. © 2011 International League Against Epilepsy. | lld:pubmed |
pubmed-article:21395567 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21395567 | pubmed:volume | 52 | lld:pubmed |
pubmed-article:21395567 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21395567 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21395567 | pubmed:pagination | e4-6 | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:meshHeading | pubmed-meshheading:21395567... | lld:pubmed |
pubmed-article:21395567 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21395567 | pubmed:articleTitle | Oculogyric crises secondary to lamotrigine overdosage. | lld:pubmed |
pubmed-article:21395567 | pubmed:affiliation | Division of Pediatric Neurology, Duke University Medical Center, Durham, North Carolina 27710, USA. | lld:pubmed |
pubmed-article:21395567 | pubmed:publicationType | Journal Article | lld:pubmed |